Pricing Log in Create free account

Beta Bionics, Inc. (BBNX) vs SiBone (SIBN)

Beta Bionics, Inc. and SiBone are both Medical Devices companies. Beta Bionics, Inc. and SiBone are of similar size ($933.8M and $892.3M). Beta Bionics, Inc. grew revenue faster over the last twelve months: 52.5% against 15.3%. SiBone has the higher net margin (−6.85% vs −61.3%) and the higher return on invested capital (−15.4% vs −68.5%). Across the 17 metrics below, SiBone leads on 12 and Beta Bionics, Inc. on 5.

Valuation

Metric BBNX SIBN Medical Devices median
P/E n/m n/m 23.22
P/S 6.12 4.10 2.34
P/B 2.84 4.80 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales 4.60 3.59 2.24
Earnings yield (10.09%) (1.73%) (10.09%)
Free cash flow yield (46.43%) (0.50%) (8.47%)

Profitability

Metric BBNX SIBN Medical Devices median
Gross margin 58.31% 79.53% 56.01%
Operating margin (69.75%) (8.31%) (15.03%)
Net margin (61.32%) (6.85%) (20.40%)
Free cash flow margin (284.13%) (2.05%) (7.24%)
Return on equity (26.16%) (8.30%) (15.32%)
Return on assets (23.45%) (6.10%) (19.72%)
Return on invested capital (68.47%) (15.40%) (10.33%)

Growth

Metric BBNX SIBN Medical Devices median
Revenue growth (TTM) 52.54% 15.30% 8.80%
EPS growth (last fiscal year) 78.95% 41.33% 29.03%
Revenue growth, 5-year CAGR — 22.32% 15.47%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BBNX SIBN Medical Devices median
Debt to equity 0.00 0.20 0.07
Current ratio 8.88 9.15 2.50
Net debt to EBITDA 3.19 5.76 0.49

Dividend

Metric BBNX SIBN Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric BBNX SIBN Medical Devices median
Market cap 933.81m 892.34m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack